Investigation of Vascular Endothelial Dysfunction, Thromboembolism and Structural Arterial Disease in Paediatric and Adolescent Inflammatory Bowel Disease (IBD)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 63
- 试验地点
- 1
- 主要终点
- Carotid-Femoral Pulse Wave Velocity (PWV)
研究概览
简要总结
Inflammatory Bowel Diseases (IBD) is a group of relapsing and remitting gut inflammatory conditions acquired due to genetic susceptibility and/or environmental triggers. The disease manifestations are being increasingly seen in young children and the life-long debilitation has a severe effect on quality of life. Limited evidence suggests, although rare, in some young IBD individuals vascular complications may ensue. This leads to increased risk of vascular problems such as thrombosis, arterial disease and stroke.
In the present project we aim to study and highlight potential vascular changes in young Inflammatory Bowel Disease (IBD) patients and compare these changes with age and gender matched controls. Vasculature will be measured in multiple ways including blood analysis in the laboratory and non-invasive, physiological measures of arterial health (e.g. ultrasound arterial scan). Our overall goal is to identify biomarkers indicative of increased risk of vascular dysfunction as this will open new avenues for early therapeutic intervention.
详细描述
Plan of Investigation:
Patients: 130 children and adolescents (8-21y) with an expected ratio of 60% (n=78) Crohn's disease (CD), 35% (n=45) Ulcerative colitis (UC) 5% (n=6) Indeterminate colitis (IC). 78 age and sex-matched controls will be investigated. Sample size calculations are based on Circulating Endothelial Cells (CECs) as the primary end-point, as suggested by an on-going study by one of the co-applicants, on healthy children and children with Kawasaki disease (Brogan P et al, ref published).
40 subjects/ group are required to detect a doubling average of CECs in CD and UC vs. control with 90% power, significance 0.05 and this should be achievable by our initial recruitment. Non-normality and the need to use non-parametric or transform prior to analysis, increases the number to 47; hence we will aim to recruit 50 to the UC group. This will provide adequate power, and is feasible based on the clinical cohort available to us.
This patient cohort is an appropriate candidate group for the present investigation as
- Evidence indicates that vascular changes that occur between 10-20 years of age are a critical determinant of future vasculature health;
- Initiation into smoking habits is most likely in teenage years and
- Other established traditional risk factors for atherosclerosis (such as hypertension, type II diabetes, or even fully established atherosclerotic disease) that would act as confounding variables, are not yet present in adolescence.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 8 Years 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Clinical diagnosis of Inflammatory bowel disease (IBD arm)
- •Aged between 8 years and 18 years at recruitment (both arms)
排除标准
- •Clinical diagnosis of Inflammatory Bowel Disease (Control arm)
- •Diagnosis of any other chronic inflammatory condition
结局指标
主要结局
Carotid-Femoral Pulse Wave Velocity (PWV)
时间窗: Once, upon recruitment
Pulse wave velocity is a measure of arterial stiffness, and correlates with cardiovascular events and all-cause mortality.
次要结局
- Plasma D-dimer level(Once, upon recruitment)
- Plasma Microparticle (MP) number(Once, upon recruitment)
- Carotid Intima Media Thickness(Once, upon recruitment)
- Plasma Microparticle (MP) pro-thrombotic potential(Once, upon recruitment)
- Circulating endothelial cells (CEC)s enumeration(Once, upon recruitment)
- Plasma C-reactive protein (CRP) level(Once, upon recruitment)
- Plasma serum amyloid A (SAA) level(Once, upon recruitment)
- Plasma Tumour Necrosis Factor Alpha (TNF-a) level(Once, upon recruitment)
- Plasma interleukin 1 beta (IL-1b) level(Once, upon recruitment)
- Plasma interleukin 1 alpha (IL-1a) level(Once, upon recruitment)
- Plasma interleukin 6 (IL-6) level(Once, upon recruitment)
- Plasma Monocyte Chemotactic Protein 1 (MCP-1) level(Once, upon recruitment)
- Plasma Vascular Endothelial Growth Factor (VEGF) level(Once, upon recruitment)
- Plasma fasting lipid levels(Once, upon recruitment)
- Plasma angiopoietin 1/2 levels(Once, upon recruitment)
- Erythrocyte Sedimentation Rate(Once, upon recruitment)
